Tg Therapeutics (TGTX) Change in Acquisitions & Divestments (2015 - 2026)

Tg Therapeutics' Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $11.2 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 86.01% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $168.4 million (down 47.04% YoY), while the FY2025 annual figure was $237.5 million, down 23.61% from the prior year.
• Change in Acquisitions & Divestments was $11.2 million for Q1 2026 at Tg Therapeutics, down from $30.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $92.3 million in Q3 2024 to a low of $11.2 million in Q1 2026.
• Historically, Change in Acquisitions & Divestments has averaged $48.3 million across 5 years, with a median of $39.9 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Change in Acquisitions & Divestments soared 358.76% in 2024, then slumped 86.01% in 2026.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $20.3 million in 2022, then grew by 16.81% to $23.7 million in 2023, then surged by 211.26% to $73.7 million in 2024, then plunged by 59.29% to $30.0 million in 2025, then tumbled by 62.5% to $11.2 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $11.2 million (Q1 2026), $30.0 million (Q4 2025), and $77.8 million (Q3 2025), per Business Quant data.